INMED PHARMACEUTICALS INC.: 10-Q filed 2020-12-17

Name: INMED PHARMACEUTICALS INC.: 10-Q filed 2020-12-17
Creator: INMED PHARMACEUTICALS INC.

What INMED PHARMACEUTICALS INC. reported in its quarterly report filed 2020-12-17 (fiscal Q1 2021): 36 published measures, 69 facts as tagged in accession 0001213900-20-043142.

This filing

Form: 10-Q (quarterly report)
Filed: 2020-12-17
Fiscal period: fiscal Q1 2021
Accession: 0001213900-20-043142 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All INMED PHARMACEUTICALS INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2020-09-30	6,603,674	USD
At 2020-06-30	7,802,597	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2020-09-30	2,109,628	USD
At 2020-06-30	1,924,279	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2020-09-30	4,494,046	USD
At 2020-06-30	5,878,318	USD
At 2019-09-30	11,469,596	USD
At 2019-06-30	14,242,904	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2020-09-30	4,497,296	USD
At 2020-06-30	5,805,809	USD
At 2019-06-30	9,837,213	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	-1,599,079	USD	92
2019-07-01 to 2019-09-30	-2,805,312	USD	92

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	-1,371,590	USD	92
2019-07-01 to 2019-09-30	-2,365,020	USD	92

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2019-07-01 to 2019-09-30	32,530	USD	92

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	-64,648	USD	92

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2019-07-01 to 2019-09-30	3,743,588	USD	92

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2020-09-30	-66,248,460	USD
At 2020-06-30	-64,649,381	USD

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	5,220,707	shares	92
2019-07-01 to 2019-09-30	5,220,707	shares	92

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2020-09-30	384,529	USD
At 2020-06-30	403,485	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	85,407	USD	92
2019-07-01 to 2019-09-30	350,482	USD	92

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2020-09-30	5,116,527	USD
At 2020-06-30	6,312,457	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2020-09-30	1,874,030	USD
At 2020-06-30	1,676,268	USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Period	Value	Unit	Days
At 2020-09-30	1,088,630	USD
At 2020-06-30	1,086,655	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2020-09-30	51,873	USD
At 2020-06-30	45,344	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	1,563,925	USD	92
2019-07-01 to 2019-09-30	2,879,650	USD	92

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	911,156	USD	92
2019-07-01 to 2019-09-30	1,961,912	USD	92

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2020-09-30	5,220,707	shares
At 2020-06-30	5,220,707	shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

Period	Value	Unit	Days
At 2020-09-30	4,497,296	USD
At 2019-09-30	11,007,231	USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2020-09-30	17,849,740	USD
At 2020-06-30	17,764,333	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2020-09-30	-172,474	USD
At 2020-06-30	-301,874	USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

Period	Value	Unit	Days
At 2019-07-01	434,660	USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

Period	Value	Unit	Days
At 2020-09-30	385,057	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2020-09-30	531,693	USD
At 2020-06-30	520,418	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2020-09-30	147,164	USD
At 2020-06-30	116,933	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2020-09-30	1,088,630	USD
At 2020-06-30	1,086,655	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2020-09-30	13,988	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2020-09-30	524,196	USD
At 2020-06-30	418,920	USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	-1,469,679	USD	92
2019-07-01 to 2019-09-30	-3,123,790	USD	92

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	624,788	USD	92
2019-07-01 to 2019-09-30	887,511	USD	92

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	21,351	USD	92
2019-07-01 to 2019-09-30	7,180	USD	92

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	27,981	USD	92
2019-07-01 to 2019-09-30	30,227	USD	92

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	21,597	USD	92
2019-07-01 to 2019-09-30	23,446	USD	92

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	5,554	USD	92
2019-07-01 to 2019-09-30	-34,004	USD	92

Inspect the source

Entity: INMED PHARMACEUTICALS INC. / CIK 0001728328
Captured: 2026-09-21T17:27:41.396Z
SEC response SHA-256: 1f73e76cc8d3847e3658f72033c4ed33ce1de4528067a6f82d159b8aa5c1b91f

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001728328.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))